BRAFMutation in Metastatic Colorectal Cancer

View Full Paper

Ask AI

Bookmark

Share

Key Points

To investigate the impact of BRAF mutations on patient outcomes in metastatic colorectal cancer.
Analyzed BRAF mutation status in patients with metastatic colorectal cancer
Evaluated treatment responses and progression-free survival rates
Included a population of patients diagnosed with metastatic disease
Patients with BRAF mutations had a lower median progression-free survival rate compared to those without
BRAF mutation status significantly influenced treatment response, suggesting tailored therapies may be needed
Notable differences in overall survival were observed based on BRAF mutation presence

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Examines BRAF mutation effects in metastatic colorectal cancer, indicating new treatment options.

Contains fulltext : 80417.pdf (Publisher’s version ) (Open Access)

No takes yet. Share an insight, caveat, or question.

Tol et al. (2009) studied this question.

View Full Paper

Ask AI

Bookmark

Share